-
Electronic (PDF)
-
Site License
-
Enterprisewide
North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
GlobalData, September 2012, Pages: 102
North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Summary
Our new report, “North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provides key market data on the North America Diabetes Care Devices market – United States and Canada. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Countries covered include United States and Canada.
- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the North America Diabetes Care Devices market.
- Key players covered include LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Eli Lilly and Company, Animas Corporation, Novo Nordisk A/S, Insulet Corporation, Sanofi and Nipro Corporation.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the North America Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Diabetes Care Devices in North America
3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
3.2 Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Diabetes Care Devices, North America, Company share (2010-2011)
4 Diabetes Care Devices In United States
4.1 Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018
4.2 Diabetes Care Devices, United States, Distribution Share (2010-2011)
4.2.1 Glucose Monitoring, United States, Distribution Share (2010-2011)
4.2.2 Insulin Delivery, United States, Distribution Share (2010-2011)
4.3 Diabetes Care Devices, United States, Company Share (2010-2011)
4.3.1 Diabetes Care Devices, United States, Company Share (2010-2011)
4.3.2 Glucose Monitoring, United States, Company Share (2010-2011)
4.3.3 Insulin Delivery, United States, Company Share (2010-2011)
5 Diabetes Care Devices In Canada
5.1 Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018
5.2 Diabetes Care Devices, Canada, Distribution Share (2010-2011)
5.2.1 Glucose Monitoring, Canada, Distribution Share (2010-2011)
5.2.2 Insulin Delivery, Canada, Distribution Share (2010-2011)
5.3 Diabetes Care Devices, Canada, Company Share (2010-2011)
5.3.1 Diabetes Care Devices, Canada, Company Share (2010-2011)
5.3.2 Glucose Monitoring, Canada, Company Share (2010-2011)
5.3.3 Insulin Delivery, Canada, Company Share (2010-2011)
6 Overview of Key Companies in North America Diabetes Care Devices Market
6.1 LifeScan, Inc.
6.1.1 Company Overview
6.1.2 Share in the North America Diabetes Care Devices Market
6.2 Medtronic, Inc.
6.2.1 Company Overview
6.2.2 Share in the North America Diabetes Care Devices Market
6.3 Bayer HealthCare AG
6.3.1 Company Overview
6.3.2 Share in the North America Diabetes Care Devices Market
6.4 F. Hoffmann-La Roche Ltd.
6.4.1 Company Overview
6.4.2 Share in the North America Diabetes Care Devices Market
6.5 Abbott Laboratories
6.5.1 Company Overview
6.5.2 Share in the North America Diabetes Care Devices Market
6.6 Becton, Dickinson and Company
6.6.1 Company Overview
6.6.2 Share in the North America Diabetes Care Devices Market
6.7 Eli Lilly and Company
6.7.1 Company Overview
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.9 Animas Corporation
6.9.1 Company Overview
6.10 Insulet Corporation
6.10.1 Company Overview
6.11 Sanofi
6.11.1 Company Overview
6.12 Nipro Corporation
6.12.1 Company Overview
6.13 ARKRAY, Inc.
6.13.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Financial Deals Landscape
8.1 Acquisition
8.1.1 LifeScan Acquires Calibra Medical
8.1.2 Arriva Medical Acquires AmMed Direct For $23 Million
8.1.3 ActiveCare To Acquire 4G Biometrics, Healthcare Technology Company
8.1.4 DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To $8.5 Million
8.1.5 Arriva Medical Acquires Direct Diabetic Source
8.1.6 Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million
8.1.7 Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million
8.2 Partnerships
8.2.1 Nextgen Healthcare Enters Into Technology Integration Agreement With Nipro Diagnostics
8.2.2 Alere Enters Into Co-Development Agreement With AT&T
8.2.3 Telcare Enters Into Licensing Agreement With Diabetech For GlucoDynamix-ADMS
8.2.4 Tethys Bioscience Enters Into Technology Integration Agreement With Lose It
8.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton, Dickinson
8.2.6 Juvenile Diabetes Research Foundation Enters Into Co-Development Agreement With Helmsley Charitable Trust And Medtronic
8.2.7 Tandem Diabetes Enters Into Licensing Agreement With DexCom
8.2.8 Roche Diagnostics Enters Into Distribution Agreement With DexCom
8.2.9 Roche Diagnostics Enters Into Research And Development Agreement With DexCom
8.2.10 Pal Health Enters Into Distribution Agreement With Surefit For Xtremityone
9 Recent Developments
9.1 Strategy And Business Planning
9.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center
9.1.2 Aug 09, 2012: Takeda Establishes Development Center In China
9.1.3 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs
9.1.4 May 22, 2012: Greatbatch To Establish New Global Headquarters
9.1.5 Mar 21, 2012: HealthMed To Expand Portfolio Of Products Beyond Organ Transplantation
9.1.6 Feb 27, 2012: Greatbatch Announces Engagement To Advance Medical Device Strategy
9.1.7 Jan 26, 2012: Nipro Diagnostics Purchases New Building, Expands Fort Lauderdale Operations
9.1.8 Jan 19, 2012: BD And Mercy/ROi Collaborate To Improve Quality Of Care And Reduce Costs
9.1.9 Oct 19, 2011: Abbott To Separate Into Two Leading Companies In Diversified Medical Products And Research-Based Pharmaceuticals
9.1.10 Oct 13, 2011: Unisense Establishes US Headquarter
9.2 Legal and Regulatory
9.2.1 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision
9.2.2 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision In Dispute With Takeda
9.2.3 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification For Medical Devices
9.2.4 Mar 30, 2012: Medtronic Reaches Settlement Of Shareholder Class Action
9.2.5 Dec 23, 2011: Glancy Binkow Announces Class Action Lawsuit Against Hospira
9.2.6 Dec 13, 2011: Medtronic Reaches Settlement With US Department of Justice
9.2.7 Nov 22, 2011: Izard Nobel Announces Class Action Lawsuit Against Hospira
9.3 Government and Public Interest
9.3.1 Jun 28, 2012: American Diabetes Association Applauds US Supreme Court Decision To Uphold Affordable Care Act
9.3.2 Jun 15, 2012: American Diabetes Association Applauds Passage Of Connecticut House Bill 5348
9.3.3 Jun 15, 2012: American Diabetes Association Applauds Federal Funding For Diabetes Research And Prevention
9.3.4 Jun 15, 2012: OSA Is Associated With Diabetic Peripheral Neuropathy: Study
9.3.5 May 23, 2012: Beta Cell Imaging Could Help Spot Diabetes Earlier: Vanderbilt University
9.3.6 Mar 13, 2012: Researchers Identify Optimal Threshold For HbA1c Test For Prediabetes
9.3.7 Mar 01, 2012: Diabetes Research Institute Develops Revolutionary Oxygen-Generating Biomaterial To Enhance Islet Survival
9.3.8 Feb 13, 2012: Blood From Periodontal Disease Can Be Used To Screen For Diabetes: NYU Study
9.3.9 Jan 20, 2012: Researchers At Brown University Develops Biochip To Measures Glucose In Saliva
9.3.10 Jan 11, 2012: American Diabetes Association Applauds Revised US State Department Policy
9.3.11 Jan 03, 2012: Maternal Liver Grafts More Tolerable For Children With Rare Disease: UCSF
9.3.12 Oct 14, 2011: MannKind To Present At 18th Annual Newsmakers In BioTech Industry Conference
9.3.13 Sep 29, 2011: Research At UC Reveals Hormone Action That Could Lead To Treatments For Type 2 Diabetes
9.4 Product News
9.4.1 Oct 28, 2011: ARKRAY's GLUCOCARD Vital And 01 Blood Glucose Meters Are Listed On DoD Uniform Formulary
9.4.2 Jun 29, 2010: Medtronic Announces STAR 3 Trial Results Confirming MiniMed Paradigm REAL-Time System Achieves Better Glucose Control Than Daily Insulin Injections In Diabetic Patients
9.4.3 Jun 25, 2010: Medtronic Begins Enrollment In ASPIRE Pivotal Study Of MiniMed Paradigm x54 System
9.4.4 Mar 17, 2010: Medtronic Announces FDA Approval Of MiniMed Paradigm REAL-Time Revel System
10 Appendix
10.1 Definitions of Markets Covered in the Report
10.1.1 Diabetes Care Devices
10.2 Research Methodology
10.3 Secondary Research
10.4 Primary Research
10.5 Models
10.6 Forecasts
10.7 Expert Panels
10.8 Consulting
10.9 Currency Conversion
10.10 Contact Us
10.11 Disclaimer
1.1 List of Tables
Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 4: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 5: Diabetes Care Devices, North America, Company share by Revenue ($m), USD Constant, 2010-2011
Table 6: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018
Table 7: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 8: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 9: Glucose Monitoring, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 10: Insulin Delivery, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Diabetes Care Devices, United States, Company Share, USD Constant, (2010-2011)
Table 12: Glucose Monitoring, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Insulin Delivery, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018
Table 15: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 16: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 17: Glucose Monitoring, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 18: Insulin Delivery, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Diabetes Care Devices, Canada, Company Share, USD Constant, (2010-2011)
Table 20: Glucose Monitoring, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Insulin Delivery, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Diabetes Care DevicesMarket Pipeline Products
Table 23: LifeScan Acquires Calibra Medical
Table 24: Arriva Medical Acquires AmMed Direct For $23 Million
Table 25: ActiveCare To Acquire 4G Biometrics, Healthcare Technology Company
Table 26: DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To $8.5 Million
Table 27: Arriva Medical Acquires Direct Diabetic Source
Table 28: Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million
Table 29: Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million
Table 30: Nextgen Healthcare Enters Into Technology Integration Agreement With Nipro Diagnostics
Table 31: Alere Enters Into Co-Development Agreement With AT&T
Table 32: Telcare Enters Into Licensing Agreement With Diabetech For GlucoDynamix-ADMS
Table 33: Tethys Bioscience Enters Into Technology Integration Agreement With Lose It
Table 34: Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton, Dickinson
Table 35: Juvenile Diabetes Research Foundation Enters Into Co-Development Agreement With Helmsley Charitable Trust And Medtronic
Table 36: Tandem Diabetes Enters Into Licensing Agreement With DexCom
Table 37: Roche Diagnostics Enters Into Distribution Agreement With DexCom
Table 38: Roche Diagnostics Enters Into Research And Development Agreement With DexCom
Table 39: Pal Health Enters Into Distribution Agreement With Surefit For Xtremityone
1.2 List of Figures
Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 4: Diabetes Care Devices, North America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 5: Diabetes Care Devices, North America, Company share (%), 2011
Figure 6: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018
Figure 7: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 8: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 9: Diabetes Care Devices, United States, Company Share (%), 2011
Figure 10: Glucose Monitoring, United States, Company Share (%), 2011
Figure 11: Insulin Delivery, United States, Company Share (%), 2011
Figure 12: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018
Figure 13: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 14: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 15: Diabetes Care Devices, Canada, Company Share (%), 2011
Figure 16: Glucose Monitoring, Canada, Company Share (%), 2011
Figure 17: Insulin Delivery, Canada, Company Share (%), 2011
Figure 18: LifeScan, Inc., Company Share (%), North America Diabetes Care Devices Market, 2011
Figure 19: Medtronic, Inc., Company Share (%), North America Diabetes Care Devices Market, 2011
Figure 20: Bayer HealthCare AG, Company Share (%), North America Diabetes Care Devices Market, 2011
Figure 21: F. Hoffmann-La Roche Ltd., Company Share (%), North America Diabetes Care Devices Market, 2011
Figure 22: Abbott Laboratories, Company Share (%), North America Diabetes Care Devices Market, 2011
Figure 23: Becton, Dickinson and Company, Company Share (%), North America Diabetes Care Devices Market, 2011
LifeScan, Inc.
Medtronic, Inc.
Bayer HealthCare AG
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Becton, Dickinson and Company
Eli Lilly and Company
Novo Nordisk A/S
Animas Corporation
Insulet Corporation
Sanofi
Nipro Corporation
ARKRAY, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
